Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer. Kono M, Saito S, Rokugo M, Egloff AM, et al. Oral Oncol 2024;152:106795.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kono M, Saito S, Rokugo M, Egloff AM, et al. Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer. Oral Oncol 2024;152:106795.
PMID: 38599127